|
|
|
Lymphoma for Clinicians:
Expert Advice Regarding Contemporary Management
(Webcast)
|
Statement of Educational Need
|
|
|
|
The growing number of therapeutic options available for patients with subtypes of non-Hodgkin lymphoma (NHL), including chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, and peripheral T-cell lymphoma, leaves many important questions currently unanswered, including the appropriate integration of novel agents and the use of prognostic markers to select therapy. Determining which treatment approach is most appropriate for a given patient requires careful evaluation of individual patient characteristics, physician expertise, and available health-system resources, which require knowledge of current clinical and experimental data in order for the optimal utilization of therapeutic agents and strategies in clinical practice. Based on the development of new, potentially more effective agents, there exists a need to increase the awareness of practicing physicians regarding the rationale for the development of novel agents, their mechanisms of action, and the proper use of these agents in the management of lymphoma, both alone and in combination with existing therapy modalities, including any important adverse effects that may arise.
|
|
|
|
top
|
|
|
To Receive A Certificate
|
|
|
|
Review the material in the Course Presentations section.
|
|
|
|
Complete the CME Posttest with a score of 4 out of 5 questions correct.
|
|
|
|
You will then be asked to register and complete a brief course evaluation.
|
|
|
|
A certificate will be automatically generated for you online.
|
|
|
|
|
|
|
|
Course Objectives
|
|
|
Upon completion of this educational activity, attendees should better be able to:
- Evaluate the use of prognostic markers to guide the therapeutic decision-making process in patients with chronic lymphocytic leukemia
- Compare and contrast conservative therapy and aggressive therapy for mantle cell lymphoma, focusing on recent clinical trial data and patient outcomes
- Discuss available and emerging management options for patients with follicular lymphoma and identify strategies to employ the optimal sequence of therapy
- Optimize therapeutic planning in patients with aggressive peripheral T-cell lymphoma based on emerging data from clinical trials demonstrating the improved management of this patient population
- Describe emerging therapies in NHL and evaluate the practical utility of novel agents based on data from clinical studies
|
|
|
|
top
|
|
|
|
|
Target Audience
|
|
|
|
This educational activity is specifically designed for hematologists, oncologists, and other healthcare professionals involved and/or interested in the management of patients with lymphoma.
|
|
|
|
top
|
|
|
|
|
Method of Participation
|
|
|
There are no fees for participating and receiving CME credit for this activity.
You must:
- read the learning objectives and faculty disclosures;
- study the educational activity;
- complete the posttest by recording the best answer to each question in the answer key
- complete the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.
Upon successfully completing the post-test and evaluation, your certificate will be made available immediately.
|
|
|
|
top
|
|
|
|
|
Joint Sponsorship
|
|
|
|
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Nebraska Medical Center, Center for Continuing Education and prIME Oncology.
|
|
|
|
top
|
|
|
|
|
Accreditation
|
|
|
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 4.5 contact hours under ANCC criteria. Provided for 5.4 contact hours under Iowa Provider #78. Provider approved by the California Board of Registered Nursing, Provider #13699 for 5.4 contact hours.
|
|
|
|
top
|
|
|
|
|
Disclaimer
|
|
|
|
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
|
|
|
|
top
|
|
|
|
|
|
